Cannabis and Alcohol Co-Use in a Smoking Cessation Pharmacotherapy Trial for Adolescents and Emerging Adults | Zendy

Erin A. McClure | Zendy; Nathaniel L. Baker | Zendy; Caitlyn O. Hood | Zendy; Rachel L. Tomko | Zendy; Lindsay M. Squeglia | Zendy; Julianne C. Flanagan | Zendy; Matthew J. Carpenter | Zendy; Kevin M. Gray | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cannabis and Alcohol Co-Use in a Smoking Cessation Pharmacotherapy Trial for Adolescents and Emerging Adults

Author(s) -

Erin A. McClure,

Nathaniel L. Baker,

Caitlyn O. Hood,

Rachel L. Tomko,

Lindsay M. Squeglia,

Julianne C. Flanagan,

Matthew J. Carpenter,

Kevin M. Gray

Publication year - 2019

Publication title -

nicotine and tobacco research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.338

H-Index - 113

eISSN - 1469-994X

pISSN - 1462-2203

DOI - 10.1093/ntr/ntz170

Subject(s) - cannabis , varenicline , smoking cessation , medicine , randomized controlled trial , psychiatry , nicotine , pathology

The co-use of cannabis and alcohol among tobacco-using youth is common. Alcohol co-use is associated with worse tobacco cessation outcomes, but results are mixed regarding the impact of cannabis on tobacco outcomes and if co-use leads to increased use of non-treated substances. This secondary analysis from a youth smoking cessation trial aimed to (1) evaluate the impact of cannabis or alcohol co-use on smoking cessation, (2) examine changes in co-use during the trial, and (3) explore secondary effects of varenicline on co-use.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research